Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -51.7% | -66.5% | 0 / 3 | -32.2% | -6.83 pp | -2.83 pp | +2.2% | 0.24 | 33.61 | 311 | −32,2% | 15,6 | −56,7% | 33.61 | 21.37 | +57,3% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.790 (close price on 2026-10-19)EPS (TTM): 231,8
Financial charts
1.Revenue & growth
VND bn311Q2/26
1.Revenue & growth
VND bn311Q2/26
2.Profit & growth
VND bn14,3Q2/26
3.Profit mix (Penman)
VND bn69,0Q2/26
4.Margins & cost structure
%13.3%Q2/26
5.Returns & cash cycle
% · days-0.0%Q2/26
6.Earnings quality & cash
VND bn464Q2/26
7.Asset structure
VND bn2.935Q2/26
8.Funding & debt health
VND bn · times2.935Q2/26
9.Revenue backlog
VND bn10,9Q2/26
10.Valuation
times · %35,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %70Q2/26
Adjusted EPS growth, latest quarter
-51.7%
Average adjusted EPS growth, 3 quarters
-66.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26